Australia's Universal Biosensors jumps on licence agreement for COVID-19 test kit

Universal Biosensors

24/12/2021 24:54

** Shares of Universal Biosensors Inc  UBI.AX  climb as much
as 6.8% to A$0.94, set to gain most since Nov. 30
    ** Medical diagnostics firm says it enters into a global
exclusive licence agreement with niche biotech solution provider
IQ Science for commercialisation of its COVID-19 detection test 
  link 
    ** Under the agreement, co to get pre-commercialisation fee
of A$50000 per year for three years
    ** As of last close, stock had doubled in value this year

 (Reporting by Navya Mittal)
 ((Navya.Mittal@thomsonreuters.com;))